Immix Biopharma Inc.
IMMX | NASDAQ
$7.20
-$0.77 (-9.66%)
At close: Nov 4, 2026, 4:00 PM ET
$7.27
+$0.07 (+0.97%)
After-hours:
Nov 5, 2026, 4:27 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -41.82M | -36.08M | -29.96M | -24.05M | -23.78M | -21.77M | -22.67M | -23.06M | -20.19M | -19.21M | -16.14M | -14.56M | -11.57M | -9.41M | -8.22M | -5.02M | -3.84M | -2.52M | -1.35M | -907.27K | -650.51K | -511.86K |
Interest Income | 1.93M | 1.12M | 555.53K | 524.67K | 696.81K | 899.67K | 1.02M | 1.06M | 990.09K | 812.02K | 572.01K | 343.43K | 156.74K | 27.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.96K |
Pretax Income | -39.88M | -34.95M | -29.4M | -23.53M | -23.09M | -20.87M | -21.66M | -22M | -19.2M | -18.4M | -15.57M | -14.22M | -11.41M | -9.38M | -8.22M | -27.18M | -26.05M | -24.69M | -24.38M | -2.38M | -2.09M | -2.01M |
Net Income | -39.92M | -34.98M | -29.44M | -23.56M | -23.13M | -20.9M | -21.61M | -21.89M | -19.02M | -18.21M | -15.43M | -14.14M | -11.39M | -9.38M | -8.23M | -27.19M | -26.05M | -24.7M | -24.38M | -2.39M | -2.11M | -2.03M |
Selling & General & Admin | 20.19M | 15.81M | 13.7M | 12.14M | 12.02M | 11.75M | 11.38M | 10.04M | 9.51M | 8.55M | 7.41M | 6.66M | 5.08M | 4.52M | 4.02M | 3.08M | 2.56M | 1.79M | 1.23M | 706.64K | 434.62K | 298.8K |
Research & Development | 21.62M | 20.26M | 16.26M | 11.91M | 11.77M | 10.02M | 11.29M | 13.02M | 10.68M | 10.66M | 8.74M | 7.9M | 6.49M | 4.89M | 4.2M | 1.94M | 1.28M | 731.22K | 126.53K | 200.62K | 215.89K | 213.06K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 41.82M | 36.08M | 29.96M | 24.05M | 23.78M | 21.77M | 22.67M | 23.06M | 20.19M | 19.21M | 16.14M | 14.56M | 11.57M | 9.41M | 8.22M | 5.02M | 3.84M | 2.52M | 1.35M | 907.27K | 650.51K | 511.86K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 109 | 497 | 45K | 98.94K | 152.7K | 179.85K | 160.04K | 129.47K | 75.61K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.82M | 36.08M | 29.96M | 24.05M | 23.78M | 21.77M | 22.67M | 23.06M | 20.19M | 19.21M | 16.14M | 14.56M | 11.57M | 9.41M | 8.22M | 5.02M | 3.84M | 2.52M | 1.35M | 907.27K | 650.51K | 511.86K |
Income Tax Expense | 33.31K | 27.9K | 37.72K | 37.24K | 40.67K | 42.02K | 41.04K | 38.34K | 34K | 30.08K | 26.42K | 23.59K | 18.45K | 13.82K | 10.27K | 6.49K | 6.15K | 6.04K | 6.01K | 16.83K | 17.21K | 17.37K |
Shares Outstanding (Basic) | 63.77M | 55.37M | 38.29M | 31.93M | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M | 8.77M |
Shares Outstanding (Diluted) | 63.77M | 55.37M | 38.29M | 31.93M | 29.98M | 29.7M | 27.54M | 29.42M | 28.79M | 23.44M | 19.92M | 18.58M | 15.04M | 13.9M | 13.23M | 13.92M | 13.88M | 13.83M | 7.58M | 7.2M | 8.77M | 8.77M |
EPS (Basic) | -0.88 | -0.92 | -0.89 | -0.78 | -0.78 | -0.71 | -0.78 | -0.87 | -0.86 | -0.95 | -0.91 | -0.94 | -0.82 | -0.69 | -0.61 | -3.32 | -3.26 | -3.18 | -3.20 | -0.30 | -0.26 | -0.27 |
EPS (Diluted) | -0.88 | -0.92 | -0.89 | -0.78 | -0.78 | -0.71 | -0.78 | -0.87 | -0.86 | -0.95 | -0.91 | -0.94 | -0.82 | -0.69 | -0.61 | -3.32 | -3.26 | -3.18 | -3.20 | -0.30 | -0.26 | -0.27 |
EBITDA | -40.28M | -35.27M | -29.07M | -23.25M | -22.88M | -20.72M | -21.54M | -21.93M | -19.15M | -18.37M | -15.56M | -14.21M | -11.41M | -9.38M | -8.22M | -27.13M | -25.95M | -24.54M | -24.2M | -2.21M | -1.96M | -1.91M |
EBIT | -40.6M | -35.67M | -29.4M | -23.53M | -23.09M | -20.87M | -21.66M | -22M | -19.2M | -18.4M | -15.57M | -14.22M | -11.41M | -9.38M | -8.22M | -27.13M | -25.95M | -24.54M | -24.2M | -2.22M | -1.96M | -1.91M |
Depreciation & Amortization | 318.38K | 398.22K | 326.63K | 277.34K | 206.26K | 150.72K | 115.39K | 77.13K | 52.6K | 28.81K | 5.47K | 2.96K | 2.14K | 2.02K | 2.14K | 2.19K | 2.24K | 2.48K | 2.47K | 2.43K | 2.39K | 2.35K |
Add to Watchlist
Select watchlists to add or remove IMMX